17-19555995-G-T
Variant summary
Our verdict is Uncertain significance. Variant got 4 ACMG points: 4P and 0B. PM2PP3_Moderate
The NM_018242.3(SLC47A1):c.854G>T(p.Gly285Val) variant causes a missense, splice region change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.0000669 in 1,614,172 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. 2/3 splice prediction tools predicting alterations to normal splicing. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_018242.3 missense, splice_region
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Uncertain_significance. Variant got 4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SLC47A1 | NM_018242.3 | c.854G>T | p.Gly285Val | missense_variant, splice_region_variant | 10/17 | ENST00000270570.8 | NP_060712.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
SLC47A1 | ENST00000270570.8 | c.854G>T | p.Gly285Val | missense_variant, splice_region_variant | 10/17 | 1 | NM_018242.3 | ENSP00000270570 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000125 AC: 19AN: 152174Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000796 AC: 20AN: 251386Hom.: 0 AF XY: 0.0000736 AC XY: 10AN XY: 135862
GnomAD4 exome AF: 0.0000609 AC: 89AN: 1461880Hom.: 0 Cov.: 33 AF XY: 0.0000564 AC XY: 41AN XY: 727242
GnomAD4 genome AF: 0.000125 AC: 19AN: 152292Hom.: 0 Cov.: 32 AF XY: 0.0000806 AC XY: 6AN XY: 74478
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Aug 08, 2022 | The c.854G>T (p.G285V) alteration is located in exon 10 (coding exon 10) of the SLC47A1 gene. This alteration results from a G to T substitution at nucleotide position 854, causing the glycine (G) at amino acid position 285 to be replaced by a valine (V). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at